Wildbird is making quarters now, as they say in military terms. Setting up the company, getting bank accounts, VAT numbers, an accountant (Randzaak Hengelo) and negotiating a management agreement.
Plan is to start in 2021 to run a new daughter company of Medspray, Wilbur’s current employer; Together with some guys in Munich in a new GmbH, to make soft mist inhaler devices and turn them into combination products with several medicines. Goal is to get two to three of these products on the market in the upcoming 4-5 years. And maybe quicker, because the daughter company will inherit one or two projects on COVID medications, that may go to market already in 2021 if the clinical trials are successful.
Fingers crossed. Warp speed ahead.